Monday, November 25, 2013

Making smarter us of the data we have for clinical trials

Pin It Now!
In an effort to improve patients and clinical trial conductors make better use of ClinicalTrials.gov, the US Government has recently signed three deals with Eli Lilly, Novartis and Pfizer to make better use of the data coming in to the government to help more patients connect with clinical trials.

With the increased use of electronic health records, the goal is to better align clinical trial studies with the patients they are trying to find.  The goal is to have each trial create an electronic target health profile.  According to Fierce Biotech IT, programs will be able to find the electronic health records of those patients who may fit the profile of an ideal patient to participate in that clinical trial.  Each of the three pharma companies participating will start the effort by doing this for fifty currently running clinical trials.  The government hopes that after this, more companies will make the target profiles and software developers will develop a software system that can bring the patients to the clinical trials.

This February at ePharma, Tom McCourt, Chief Commercial Officer of Ironwood Pharmaceuticals will be on hand to discuss how his company began work with the University of Michigan and UCLA to better improve their electronic capabilities - ultimately showing how the healthcare delivery system can be improved for the better by better leveraging the capabilities we have with evolving IT and healthcare systems.  For more information on this session and the rest of the program, download the digital agenda. The ePharma Summit will take place February 10-12, 2014 in New York.  If you'd like to join Tom, as a reader of this blog when you register to join us an mention XP1906BLOG, you'll save $100 off the current rate!*  

If you could harness the power of big data to make your work at a Pharma company better or more accessible for patients, what you would you do?
Post a Comment